ABX advanced biochemical compounds is a global frontrunner in radiopharmaceuticals, with a focus on positron emission tomography (PET) tracers. We develop and produce all compounds and components for any kind of radiotracer – from PET and SPECT precursors, PET reagent kits and cassettes, to complete radiopharmaceutical drug production in GMP environment.

Based in Radeberg, Germany, and founded in 1997, our team of more than 350 employees is specialised in custom synthesis and manufacturing of precursors and peptides according to GMP for active pharmaceutical ingredients. Thanks to our expertise combined with bleeding edge equipment, we reach highest research, production, and quality standards.

For example, we operate a hot lab for R&D of new radiopharmaceutical kits and cassettes for our own product portfolio and in cooperation with pharmaceutical companies. Our extensive laboratory space enables us to perform stability studies of our products and in-house sterility testing of radioactive pharmaceuticals. Thanks to our production of aseptic excipients and sterile disposables, we are largely independent from external sourcing. We are also authorized producer of radiopharmaceutical drugs. Furthermore, we are experts in ASMFs, US-DMFs and technical documents for reagent kits, cassettes, PET and SPECT precursors.

Biotechnology

Life Sciences

Medical Devices

Pharmaceutical

ABX advanced biochemical compounds GmbH

ABX advanced biochemical compounds GmbH's headquarters in Germany

Description

People (8)

Jobs (0)

Other offices